Updates in diagnosis and management of inflammatory bowel disease

Curr Probl Pediatr Adolesc Health Care. 2020 May;50(5):100785. doi: 10.1016/j.cppeds.2020.100785. Epub 2020 May 10.

Abstract

Worldwide incidence of inflammatory bowel disease (IBD) is stable in developed countries, but rising in developing countries. Presenting symptoms of IBD can be highly variable. New imaging modalities, a greater armamentarium of therapeutic options, and a greater understanding of complication risks have changed the diagnosis and management of pediatric inflammatory bowel diseases. Effective teamwork among those who care for pediatric patients with IBD minimizes complications and maximizes desired outcomes.

Publication types

  • Review

MeSH terms

  • Biological Products / therapeutic use
  • Diet
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / diagnosis*
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / pathology*
  • Pediatrics / organization & administration*
  • Phenotype
  • Primary Health Care
  • Self-Management

Substances

  • Biological Products
  • Gastrointestinal Agents
  • Immunologic Factors